Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03274466 · ClinicalTrials.gov registry record · NA

Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty

A NA study, sponsored by KCI USA.

Completed
Registry status
NA
Development phase
294
Enrollment target

NCT03274466: Completed NA study, sponsored by KCI USA.

NCT03274466 is a NA study that has completed, run by KCI USA. The registered enrollment target is 294 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03274466, a NA study, has completed, sponsored by KCI USA.

COMPLETED
Registry status
NA
Development phase
294 participants
Enrollment target

Study Summary

This study evaluates surgical site complications in subjects undergoing revision of a total knee arthroplasty when closed incision negative pressure therapy is used to manage the closed incision, as compared to a standard of care dressing.

Primary Outcome

The subject incidence of Investigator-assessed surgical site complications (SSCs) within 90 days of TKA revision. SSCs include any of the following: * Superficial Surgical Site Infection (SSI) * Deep SSI * Full thickness skin dehiscence * Seroma or hematoma requiring drainage or surgery * Skin necrosis * Continued drainage at the time of dressing removal

Interventions

  • DEVICE Closed Incision Negative Pressure Therapy (ciNPT)
  • DEVICE Standard of Care Dressing

Trial Details

FieldValue
Enrollment Target 294 participants
Start Date 2017-12-05
Est. Completion 2019-12-19
Phase NA
KCI USA

11 total trials

What the finished NCT03274466 record still lists

NCT03274466 is an interventional study that assigns participants to a tested intervention. The registered 294 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).

The record links to 0 conditions, and to 2 interventions - of which Closed Incision Negative Pressure Therapy (ciNPT) is the first listed.

NCT03274466 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03274466 about?

NCT03274466 is a clinical study titled "Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty". This study evaluates surgical site complications in subjects undergoing revision of a total knee arthroplasty when closed incision negative pressure therapy is used to manage the closed incision, as compared to a standard of care dressing.

What is the current status of trial NCT03274466?

This trial is currently completed. It is a NA study. The enrollment target is 294 participants. The study started on 2017-12-05. Estimated completion is 2019-12-19.

What interventions are being tested in trial NCT03274466?

The interventions under investigation include: Closed Incision Negative Pressure Therapy (ciNPT) (DEVICE), Standard of Care Dressing (DEVICE).

Who is sponsoring clinical trial NCT03274466?

This trial is sponsored by KCI USA, which has 11 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03274466's enrollment target sits among peer trials

294 373rd of 2000 higher than 1,626 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05775159 · 294 participants · Phase 2

    Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

  • NCT06262113 · 294 participants · NA

    A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1

  • NCT06338865 · 294 participants · NA

    Short Title: Standard vs. Lower Pressure Pneumoperitoneum

  • NCT06395467 · 294 participants · NA

    Integrated Treatment for Enhancing Growth in Recovery During Adolescence

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03274466, the US trial registry maintained by the National Library of Medicine. NCT03274466 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.